Pluvicto (lutetium Lu 177 vipivotide tetraxetan) is a medicine that is used to treat prostate cancer in adults. Pluvicto may be used to treat PSMA-positive prostate cancer that has spread to other ...
The decision means Northern Ireland remains the only country in the UK where patients with this stage of prostate cancer are ...
A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment ...
Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have launched a clinical trial, called ANDROMEDA, to ...